Here is some breaking news on NovogenApparently, and I am still...

Here is some breaking news on Novogen

Apparently, and I am still trying to confirm this but the source is very
reliable, an affiliate TV station NBC reported early results from the
Ovarian trial of 20%-30% response rates with no side-effects. This result
would have been from the mono-therapy phase of the trial and is EXCELLENT
bearing in mind that this response rate is better than recent cancer drugs
recently approved by the FDA. The company is expecting much better results
from the combination of phenoxodiol with cisplatin, a chemo therapy.

It looked to me that NVGN in the states was about to turn based upon the
volume traded, and Marshall Edwards in the UK has been ticking up recently
and the volume last night was 10,000 shares, which is a truckload for this
stock in one single trading session.

I will try and find the TV report and post later. Looks like the price is
about to snap, crackle and pop. Go you good thing.

I hold NRT